WHO WE HELP
PHARMA AND BIOTECH
We enable pharmaceutical and biotech companies to launch their medicines commercially by providing full commercialization capabilities based on registration and market authorisation, price and reimbursement.
For more information on partnerships, click here.
HEALTHCARE PROVIDERS
The physicians, hospitals, clinics and pharmacies who face patients’ unmet needs due to a lack of commercially available therapies in their home countries can count on FarmaMondo to source unlicensed medicines in compliance with all import regulations.
Hospital pharmacists’ work is a never-ending challenge.
of hospital pharmacists reported that medicine shortages are a current problem in their hospitals.
FarmaMondo understands your needs and expectations in addressing your hospital shortages. We realize the urgency, we are aware of the applicable regulatory routes, and we adapt to all the common procurement mechanisms and administrative procedures in relation to unlicensed medicines. Contact FarmaMondo to overcome product shortages your hospital is facing.
* The European Association of Hospital Pharmacists (EAHP). EAHP’s 2023 Medicines Shortages Report.
INDIVIDUAL PATIENTS
According to the applicable regulations related to the supply of medicines, all requests for access to medicines must come from a healthcare provider. The FarmaMondo group includes Farmacia Centrale, a Swiss international dispensing pharmacy serving patients with valid prescriptions.
Please contact: farmaciacentrale@farmamondo.com
Alternatively, if you are a patient or visiting this site on behalf of a patient who suffers from an unmet medical need, please contact your healthcare provider (e.g. doctor, pharmacist or hospital). FarmaMondo, once contacted by your healthcare provider, will discuss the options for gaining access to the requested therapy.
PATIENT ADVOCACY ORGANIZATIONS
We constantly work together with patient advocacy organisations (PAOs) to gain awareness of unmet patient needs. PAOs play a critical role as a trusted resource for their patients, providing timely and accurate information about the process for accessing specialty medicines.
